By
AmyT on
November 24, 2008
I’ve been confused for a while about the controversy over “evidence-based medicine.” Some doctors think it is correct; others don’t. We patients take it for granted that there is solid scientific evidence behind the drugs and treatments our doctors prescribe. So have we been misled there?
The Center for Evidence-Based Medicine (yes, there is one!) describes it as “the conscientious, explicit and judicious use of current best evidence in making decisions about the care of…
Read more »
By
AmyT on
November 20, 2008
So my “mole” who attended the Diabetes Technology Society meeting in Maryland last week got back to me, and the news was kind of disappointing. On the whole, it doesn’t sound like there’s anything particularly new under the sun for us PWDs at the moment; it’s all about more baby steps in research and development.
But Aaron Kowalski, Research Director of the JDRF, might disagree with me there. He delivered a keynote address entitled “Accelerating…
Read more »
By
AmyT on
November 12, 2008
While we’re on the topic of diabetes technologies and advancements this week, I’d like to share what I’ve learned about two more companies working on some alluring diabetes innovations.
DiaSome Pharmaceuticals, located in Conshohoken, PA, is developing a “proprietary nanotechnology cell-receptor targeting system” designed to deliver insulin to the hepatocyte cells in the liver via both oral and injectable drug routes. According to their documentation, “the site-specific targetting of insulin essentially restores ‘normal physiology’ to…
Read more »
By
AmyT on
November 12, 2008
While we’re on the topic of diabetes technologies and advancements this week, I’d like to share what I’ve learned about two more companies working on some alluring diabetes innovations.
DiaSome Pharmaceuticals, located in Conshohoken, PA, is developing a “proprietary nanotechnology cell-receptor targeting system” designed to deliver insulin to the hepatocyte cells in the liver via both oral and injectable drug routes. According to their documentation, “the site-specific targetting of insulin essentially restores ‘normal physiology’ to…
Read more »
By
AmyT on
November 10, 2008
On Wednesday of this week, the eighth annual Diabetes Technology Meeting convenes in Bethesda, MD, for a three-day event (spanning this year’s World Diabetes Day on Thursday) that will survey the latest technological advances for people with diabetes. How I’d love to be a fly on the wall at that conference!
Nevermind that I’ve been trying to gain press access to this meeting for at least the last 3 years; I have a mole this…
Read more »
